REPRO-MED Systems (KRMD)
NASDAQ:KRMD
KRMD Stock Chart & Stats
$4.34
<$0.01(0.25%)
At close: 4:00 PM EST
$4.34
<$0.01(0.25%)
Day’s Range― - ―
52-Week Range$2.08 - $6.61
Previous CloseN/A
Volume31.78K
Average Volume (3M)198.68K
Market Cap
$201.25M
Enterprise Value$194.02M
Total Cash (Recent Filing)$8.87M
Total Debt (Recent Filing)$3.50M
Price to Earnings (P/E)―
Beta1.13
Next Earnings
May 06, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding46,370,434
10 Day Avg. Volume166,933
30 Day Avg. Volume198,682
Financial Highlights & Ratios
PEG Ratio1.81
Price to Book (P/B)15.74
Price to Sales (P/S)6.52
P/FCF Ratio-570.81
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue4.72
Enterprise Value/Gross Profit7.83
Enterprise Value/Ebitda-93.62
Forecast
1Y Price Target
$6.75Price Target Upside55.53% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-0.03
Revenue Forecast (FY)$48.48M
Bulls Say, Bears Say
Bulls Say
Financial PerformanceReported revenue above analyst expectations combined with positive operating cash flow and a solid cash balance strengthens financial resilience and supports growth initiatives.
International ExpansionEuropean transition to pre-filled syringe formats positions the company to capture meaningful market share as hospitals and clinics adopt compatible devices.
Regulatory ApprovalsU.S. clearance of a second infusion drug enables entry into infusion clinics and supports expansion into higher-volume care settings.
Bears Say
Clinical Trial ActivityLower clinical trial activity could shrink the service backlog and delay revenue recognition from development partnerships.
Earnings VolatilityWeakness in services revenue could increase earnings volatility and complicate analyst forecasting.
Pharma Services Revenue DeclineA decline in revenue from pharmaceutical services reduces top-line growth and may pressure revenue guidance.
REPRO-MED Systems News
KRMD FAQ
What was REPRO-MED Systems’s price range in the past 12 months?
REPRO-MED Systems lowest stock price was $2.08 and its highest was $6.61 in the past 12 months.
What is REPRO-MED Systems’s market cap?
REPRO-MED Systems’s market cap is $201.25M.
When is REPRO-MED Systems’s upcoming earnings report date?
REPRO-MED Systems’s upcoming earnings report date is May 06, 2026 which is in 21 days.
How were REPRO-MED Systems’s earnings last quarter?
REPRO-MED Systems released its earnings results on Mar 12, 2026. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.02 by $0.01.
Is REPRO-MED Systems overvalued?
According to Wall Street analysts REPRO-MED Systems’s price is currently Undervalued.
Does REPRO-MED Systems pay dividends?
REPRO-MED Systems does not currently pay dividends.
What is REPRO-MED Systems’s EPS estimate?
REPRO-MED Systems’s EPS estimate is -0.02.
How many shares outstanding does REPRO-MED Systems have?
REPRO-MED Systems has 46,370,434 shares outstanding.
What happened to REPRO-MED Systems’s price movement after its last earnings report?
REPRO-MED Systems reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.02. Following the earnings report the stock price went down -0.696%.
Which hedge fund is a major shareholder of REPRO-MED Systems?
Currently, no hedge funds are holding shares in KRMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
REPRO-MED Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
50.99%
12-Months-Change
Fundamentals
Return on Equity
-21.71%
Trailing 12-Months
Asset Growth
-1.05%
Trailing 12-Months
Company Description
REPRO-MED Systems
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
KRMD Company Deck
KRMD Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strong operational and financial performance: double-digit revenue growth (Q4 +23%, FY +22%), significant international expansion (International Core +71% Q4, +80% FY), regulatory wins (EU MDR for FREEDOM60, 510(k) for RYSTIGGO), expanded pipeline and positive adjusted EBITDA and cash flow for the year. Headwinds include milestone-driven PST revenue variability (-30% Q4), modest gross margin pressure from materials and tariffs, a relatively small cash balance ($8.9M) and execution/timing risks around prefill rollouts, 510(k) approvals and geopolitical factors. Overall, the positives — consistent high revenue growth, international share gains, regulatory clearances, pipeline expansion and movement to profitability — outweigh the manageable risks and timing uncertainties.View all KRMD earnings summariesKRMD Stock 12 Month Forecast
Average Price Target
$6.75
▲(55.53% Upside)
Technical Analysis
InfuSystem Holdings
―
Orasure Technologies
―
Utah Medical Products
―
Microbot Medical
―
Sharps Technology, Inc.
―
Ownership Overview
14.62% Insiders
8.34% Mutual Funds
24.28% Other Institutional Investors
45.11% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---